India's robotic surgery market accelerates with innovative models and expanding access

India is rapidly transforming its surgical landscape, driving growth in robotic surgery through innovative financing, wider hospital adoption, and emphasis on outcomes, aiming to make advanced surgical care accessible beyond major urban centres.

For robotic surgery to take hold in India, the decisive question was not whether the machines worked, but whether hospitals could keep them busy enough to justify the capital cost. That pushed advocates around Dr Mahendra Bhandari and the Vattikuti Foundation towards a distinctly Indian formula built on throughput, training and wider institutional adoption. ETHealthWorld reported in September 2017 that 47 hospitals in India had access to 51 surgical robots and 275 trained robotic surgeons, while The Times of India had already described a sharp rise over the previous decade, from seven robots, 861 procedures and two trained surgeons to 35 robots, 11,790 procedures and 187 trained surgeons. (health.economictimes.indiatimes.com)

The commercial arithmetic was unforgiving. PTI reported in June 2016 that Vattikuti Technologies, promoted by Raj Vattikuti and acting as the sole distributor in India for Intuitive Surgical’s da Vinci systems, had installed 32 robots and wanted to sell 15 to 20 a year at prices ranging from $1.2 million to $2 million. Its customers already included Apollo, Fortis, Medanta, Max and Manipal. Raj Vattikuti later told ETHealthWorld that one answer was a “Pay For Use” arrangement, designed to reduce the upfront risk for hospitals that were unsure how quickly case volumes would build. (business-standard.com)

The figures published in 2017 suggest a market growing quickly, even if the ambitions shifted from one interview to the next. Bhandari told ETHealthWorld that India had 51 robots, 47 hospitals and 275 trained robotic surgeons. Two months later Raj Vattikuti said the country had more than 50 robots, more than 300 trained surgeons and about 700 robotic-assisted operations a month, and expected to finish the year with nearly 70 systems in place. He spoke then of a possible 200 robots carrying out about 25,000 procedures by 2020, while Business Standard, carrying IANS, described a parallel goal of more than 20,000 robotic-assisted surgeries a year and a bid to make India the world’s second-largest market for robotic surgery after the US. These were projections rather than audited outcomes, but they show how fast expectations were being revised upwards. (health.economictimes.indiatimes.com)

The spread was not confined to large private hospital chains in the biggest cities. Business Standard reported that Vattikuti Foundation activity had already reached Coimbatore, Nagpur, Vizag, Indore and Mohali, and that robots were in Army Hospital Delhi, AIIMS Delhi, Delhi Cancer Institute and PGI Chandigarh, with AIIMS Jodhpur, AIIMS Rishikesh and Safdarjung Hospital also in discussions. Bhandari argued separately to ETHealthWorld that public institutions should host robotic platforms if costs were to come down far enough for ordinary patients to benefit, and he later told IANS: “With robotic surgeries, our mission was not to segregate the poor and rich.” (business-standard.com)

For Bhandari, however, the machine was only part of the case. In his ETHealthWorld interview he said: “The differentiator between a good surgeon and others is the quality of outcomes.” He complained that Indian surgeons generated far more practical knowledge than they published, and said hospitals needed better databases and stronger long-term follow-up if they were to prove that results were durable. He also argued that doctors were being asked to do too much non-doctoral work, estimating that 50 to 60 per cent of unsuitable tasks could be shifted to paramedics. Raj Vattikuti, speaking separately to ETHealthWorld, made a related point from the training side, saying surgeons first had to become comfortable with 3D vision and robotic instrument manoeuvring before the technology could be used efficiently. (health.economictimes.indiatimes.com)

The public-facing argument for robotic surgery was already being made in practical, rather than futuristic, terms in 2016. Reporting from Yenepoya Medical College Hospital in Mangaluru, The Times of India said Bhandari described affordability for poorer patients as the field’s “ultimate objective” and linked the technology to shorter hospital stays, quicker wound healing and lower blood loss. The same report said Yenepoya was the first institution in Dakshina Kannada district to introduce the technology, underlining how much of the early contest was about getting advanced surgical tools beyond a handful of metropolitan flagships. (timesofindia.indiatimes.com)

By 2025, Bhandari was describing a more mature phase of the field. In Express Healthcare he said the important advances now included AI-assisted, real-time 3D magnified views of the surgical target, smaller and more flexible robotic systems, and the integration of 3D visualisation and augmented reality to improve surgical accuracy. He added that virtual reality simulation, haptic feedback and proficiency-based training could shorten learning curves. Yet he also said the barriers remained familiar: high costs, infrastructure limitations outside major urban centres, training gaps and limited access to the technology. (expresshealthcare.in)

That continuity may be the clearest lesson from India’s experience. The country did not build a robotic surgery market simply by buying imported machines. It built one by connecting expensive equipment to utilisation, training, hospital networks and a still unfinished argument about access. The numbers quoted by Vattikuti-linked executives in 2016 and 2017 varied by date and publication, but they point in the same direction: robotic surgery was moving from a niche capability into a broader operating model. Even in 2025, Bhandari’s emphasis had scarcely shifted. The promise, he said, was that surgical innovation would “percolate to the peripheral part of India benefitting the underprivileged population.” (business-standard.com)

Disclaimer: This content is intended for informational purposes only. Readers are advised to exercise their own judgement, conduct due diligence, or consult a qualified expert before acting on any information provided.